Drug Database
Back to search

Germany· DE-A57-7e225f851fd5fef6

Gentamicinsulfat Smartpractice Europe

A gentamicin product containing gentamicin sulfate, registered in Germany by Smartpractice Europe Gmbh. The same ATC class is registered in 5 of our 19 countries.

ATC D06AX07

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedGentamicinsulfat Smartpractice EuropeATCD06AX07REGISTER NO.DE-A57-7e225f851fd5fe…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gentamicin sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gentamicin is registered in 5 of 19 countries.

Countries holding a registration under ATC D06AX07 (gentamicin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 3 of them publish a price we can compare per daily dose
Search gentamicin products by name

Gentamicin · ATC D06AX07

5 / 19 countries

  • Finlandprice
  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Gentamicin Sulfate
Manufacturer
Smartpractice Europe Gmbh
Country
Germany (DE)
ATC code
D06AX07
ATC class
Gentamicin
Defined daily dose
2.5 mg, T
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

21 interactions on record for gentamicin.

Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check gentamicin against other medicinesHow interaction checks work

Gentamicin · interactions on record

21 records

  • 21 moderate

Most severe, free to view

  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • NeomycinB05CA09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gentamicin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gentamicin products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Gentax, Refobacin
  • Bulgaria · Гентамицин Актавис, Гентамицин Софарма
  • Czechia · Gentamicin Polpharma
  • Denmark · Gentamicin Panpharma
  • Estonia · Gentamicin Medochemie
  • United Kingdom (Northern Ireland) · Gentamicin Amdipharm Uk, Gentamicin Intrathecal Zentiva Pharma Uk Limited
  • Hungary · Gentamicin Wagner
  • Ireland · Gentamicin Pinewood Laboratories, Genticin
  • Italy · Ciclozinil, Gentalyn
  • Lithuania · Gentamicin Pph
  • Malta · Gentamicin Medochemie
  • Netherlands · Garacol, Gentamicine-Pos
  • Norway · Gentamicin Panpharma
  • Poland · Garamycin, Gentamicin Wzf
  • Portugal · Cronocol, Gentamicina Basi
  • Sweden · Gentamicin Panpharma
  • Slovakia · Garamycin Schwamm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/734be045-b7e8-4424-a641-0f946630359f
GET /v1/drugs/734be045-b7e8-4424-a641-0f946630359f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Cutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Gentamicin Sulfate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about gentamicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console